<p>Our research introduces a unique refractive index (RI) biosensor utilizing surface plasmon resonance (SPR) for the detection of cancerous cells. The sensor design incorporates two elliptical channels, two elliptical air holes, and four circular air holes, ensuring manufacturing simplicity. Gold (Au) is employed as the plasmonic layer, while Tantalum Pentoxide (<InlineEquation ID="IEq1"> <EquationSource Format="TEX">\(\textrm{Ta}_2\textrm{O}_5\)</EquationSource> </InlineEquation>) is selected as the oxide coating owing to its superior performance in enhancing analyte interaction. The proposed PCF-SPR structure benefits from two large elliptical air holes, reducing fabrication complexity and minimizing light leakage. Its performance is numerically investigated using the finite element method (FEM). Optimized structural parameters yield a maximum wavelength sensitivity (WS) of 10,000 nm/RIU and 19,000 nm/RIU for channels 1 and 2, respectively. The highest amplitude sensitivity (AS) reaches 374.35 <InlineEquation ID="IEq2"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation> and 888.52 <InlineEquation ID="IEq3"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation>, with peak figures of merit (FOM) of 135 <InlineEquation ID="IEq4"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation> in ch-1 and 179 <InlineEquation ID="IEq5"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation> in ch-2. When both channels are filled with the same analyte, the sensor demonstrates a remarkable WS of 18,000 nm/RIU, angular sensitivity of 1456.29 <InlineEquation ID="IEq6"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation>, and FOM of 274 <InlineEquation ID="IEq7"> <EquationSource Format="TEX">\(\textrm{RIU}^{-1}\)</EquationSource> </InlineEquation>, along with a broad RI detection range of 1.28−1.42. Furthermore, it efficiently detects malignant cells, achieving a maximum WS of 11,000 nm/RIU with a wavelength resolution of <InlineEquation ID="IEq8"> <EquationSource Format="TEX">\(9.09 \times 10^{-6}\)</EquationSource> </InlineEquation>RIU for cervical (HeLa) cells. The proposed biosensor, with dual-channel analyte sensing, broad RI range, and outstanding sensitivity, offers potential for simultaneous detection of biomolecules, glucose, carcinogenic substances, and other chemical compounds.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Optimal gold and oxide coating selection for a novel dual-elliptical channel PCF sensor for concurrent detection of two distinct analytes

  • Md. Tanvir Hossain,
  • Md. Arafat Rahman,
  • Abror Jawad

摘要

Our research introduces a unique refractive index (RI) biosensor utilizing surface plasmon resonance (SPR) for the detection of cancerous cells. The sensor design incorporates two elliptical channels, two elliptical air holes, and four circular air holes, ensuring manufacturing simplicity. Gold (Au) is employed as the plasmonic layer, while Tantalum Pentoxide ( \(\textrm{Ta}_2\textrm{O}_5\) ) is selected as the oxide coating owing to its superior performance in enhancing analyte interaction. The proposed PCF-SPR structure benefits from two large elliptical air holes, reducing fabrication complexity and minimizing light leakage. Its performance is numerically investigated using the finite element method (FEM). Optimized structural parameters yield a maximum wavelength sensitivity (WS) of 10,000 nm/RIU and 19,000 nm/RIU for channels 1 and 2, respectively. The highest amplitude sensitivity (AS) reaches 374.35 \(\textrm{RIU}^{-1}\) and 888.52 \(\textrm{RIU}^{-1}\) , with peak figures of merit (FOM) of 135 \(\textrm{RIU}^{-1}\) in ch-1 and 179 \(\textrm{RIU}^{-1}\) in ch-2. When both channels are filled with the same analyte, the sensor demonstrates a remarkable WS of 18,000 nm/RIU, angular sensitivity of 1456.29 \(\textrm{RIU}^{-1}\) , and FOM of 274 \(\textrm{RIU}^{-1}\) , along with a broad RI detection range of 1.28−1.42. Furthermore, it efficiently detects malignant cells, achieving a maximum WS of 11,000 nm/RIU with a wavelength resolution of \(9.09 \times 10^{-6}\) RIU for cervical (HeLa) cells. The proposed biosensor, with dual-channel analyte sensing, broad RI range, and outstanding sensitivity, offers potential for simultaneous detection of biomolecules, glucose, carcinogenic substances, and other chemical compounds.